Actionnariat et activité des initiés pour Compass Therapeutics, Inc. (CMPX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.83 |
| Capitalisation | $330M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-04-29 | Lerner Neil | P-Purchase | 15,000 | $28K |
| 2026-04-29 | Anderman Jonathan | P-Purchase | 25,000 | $47K |
| 2026-04-29 | Anderman Jonathan | A-Award | 25,000 | $47K |
| 2026-04-29 | Lerner Neil | A-Award | 15,000 | $28K |
| 2026-02-08 | Schuetz Thomas J. | F-InKind | 36,687 | $239K |
| 2026-01-09 | Schuetz Thomas J. | F-InKind | 46,777 | $250K |
| 2026-01-02 | Shin Barry | A-Award | 670,000 | $3.5M |
| 2026-01-02 | Shin Barry | A-Award | 125,000 | $646K |
| 2026-01-02 | Sirard Cynthia | A-Award | 1,000,000 | $5.2M |
| 2026-01-02 | Schuetz Thomas J. | A-Award | 250,000 | $1.3M |
Bilan (10 ans)
| Année | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $57.5M | $25.3M | $47.1M | $144.5M | $34.9M | $24.2M | $43.5M | $30.6M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | $151.7M | $128.2M | $83.2M | $178.3M |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $58.9M | $26.2M | $50.2M | $147.1M | $194.8M | $153.9M | $132.8M | $209.8M |
| Immobilisations Corporelles | $5.4M | $3.8M | $1.1M | $6.3M | $4.5M | $2.7M | $7.1M | $9.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $64.6M | $30.4M | $51.9M | $153.8M | $199.6M | $156.9M | $140.4M | $219.6M |
| Dettes Fournisseurs | $1.7M | $629000 | $1.1M | $867000 | $3.4M | $4.1M | $2.2M | $1.6M |
| Dette à Court Terme | $3.7M | $5.6M | $7.5M | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $8.5M | $9.8M | $10.1M | $10.6M | $16.2M | $7.8M | $8.9M | $14.0M |
| Dette à Long Terme | $11.1M | $9.3M | $1.9M | 0 | 0 | 0 | 0 | $8.8M |
| Passifs Totaux | $149.4M | $149.0M | $12.0M | $13.7M | $18.0M | $8.3M | $15.2M | $22.8M |
| Réserves | -$87.2M | -$121.9M | -$151.4M | -$233.6M | -$272.8M | -$315.3M | -$364.7M | -$431.2M |
| Capitaux Propres | -$84.8M | -$118.6M | $39.9M | $140.1M | $181.6M | $148.5M | $125.2M | $196.8M |
| Dette Totale | $14.8M | $14.9M | $9.3M | $4.0M | $2.9M | $1.7M | $6.6M | $9.8M |
| Dette Nette | -$42.8M | -$10.4M | -$37.7M | -$140.5M | -$183.7M | -$150.7M | -$120.1M | -$199.1M |
| Fonds de Roulement | $50.4M | $16.4M | $40.1M | $136.5M | $178.6M | $146.1M | $123.9M | $195.9M |
Santé financière
| Dette / Capitaux propres | 0.06 |
| Ratio de liquidité | 11.22 |
Rentabilité
| Rentabilité des capitaux propres | -38.71% |
| Rentabilité du capital investi | -46.15% |
| Rentabilité des actifs | -38.62% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: BCYC · CRVS · FDMT · FULC · GOSS · KALV · LXRX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CMPX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions